Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002101389 | SCV002394435 | likely benign | not provided | 2024-07-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003339926 | SCV004067697 | uncertain significance | Inborn genetic diseases | 2023-07-19 | criteria provided, single submitter | clinical testing | The c.6976A>G (p.T2326A) alteration is located in exon 6 (coding exon 6) of the FAT4 gene. This alteration results from a A to G substitution at nucleotide position 6976, causing the threonine (T) at amino acid position 2326 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005025702 | SCV005662370 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-06-12 | criteria provided, single submitter | clinical testing |